(Q68828726)

English

The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer

scientific article published on 01 October 1974

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

title

The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

author name string

E Cameron

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

A Campbell

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

publication date

1 October 1974

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

published in

Chemico-biological Interactions

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

volume

9

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

page(s)

285-315

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

Identifiers

DOI

10.1016/0009-2797(74)90019-2

1 reference

stated in

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

Europe PubMed Central

PubMed ID

4430016

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4430016%20AND%20SRC:MED&resulttype=core&format=json

(Q68828726)

The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)